Last reviewed · How we verify

NCT05564910

Computerized Cardiotocography and Maternal Coffee Habits

Completed Last updated 4 October 2022
What this trial tests

trial in Prenatal Care in 134 participants. Completed in 28 September 2022.

Timeline
1 July 2022
Primary endpoint
30 August 2022
28 September 2022

Quick facts

Lead sponsorUniversity of Campania Luigi Vanvitelli
StatusCompleted
Study typeOBSERVATIONAL
Enrollment134
Start date1 July 2022
Primary completion30 August 2022
Estimated completion28 September 2022
Sites1 location across Italy

Conditions studied

Sponsor

University of Campania Luigi Vanvitelli

Who can join

Adults 18 to 50, female only, with Prenatal Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study includes pregnant women referred for foetal antepartum computerized cardiotocography (cCTG) monitoring as outpatients. Pregnant women were divided into two groups based on their coffee intake: the coffee group and the control group. Each pregnant woman had cCTG. Two doctors assessed and recorded the amount of coffee taken by pregnant women before the CTG.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Prenatal Care

Currently open trials in the same condition.

Other University of Campania Luigi Vanvitelli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05564910.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing